Latest Posts
About This Stock
More About This Stock
Read
Biomica Announces Closing Of $20 Million Financing Round Led By Shanghai Healthcare Capital

Article By:
TalkMarkets Newswire
Thursday, April 27, 2023 8:00 AM EDT
Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), today announced that it has closed a financing round of $20 million
In this article: EVGN
Evogene Offers An Excellent Risk/Reward Ratio
What do you currently think about $EVGN? Do you agree with this analysis?
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
Evogene Offers An Excellent Risk/Reward Ratio
I'm convinced. I'm picking up some $EVGN.
Evogene Offers An Excellent Risk/Reward Ratio
Great article, very thorough! I think $EVGN is extremely undervalued. It's at its lowest price ever right now and truly a bargain.